Evidence map›Paper›PMID 32086385›Full record

ArticleTobacco control2021

Costs of vaping: evidence from ITC Four Country Smoking and Vaping Survey.

Kai-Wen Cheng, Ce Shang, Hye Myung Lee, Frank J Chaloupka, Geoffrey T Fong, Ron Borland, Bryan W Heckman, Sara C Hitchman, Richard J O'Connor, David T Levy and 1 more

Abstract read
In one paragraph

Article in Tobacco control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Selective Reduction of Socioeconomic Disparities in the Experimental Tobacco Marketplace: Effects of Cigarette and E-cigarette Flavor Restrictions.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kai-Wen ChengDepartment of Health Administration, Governors State University, University Park, Illinois, USA kcheng@govst.edu.ORCID 0000-0002-5508-2280
Ce ShangDepartment of Pediatrics and Oklahoma Tobacco Research Center, University of Oklahoma Stephenson Cancer Center, Oklahoma City, Oklahoma, USA.
Hye Myung LeeHealth Policy Center, Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, Illinois, USA.
Frank J ChaloupkaHealth Policy Center, Institute for Health Research and Policy, University of Illinois at Chicago, Chicago, Illinois, USA.
Geoffrey T FongDepartment of Psychology and School of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada.ORCID 0000-0001-9098-6472
Ron BorlandSchool of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0003-0059-178X
Bryan W HeckmanPsychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0003-4148-2467
Sara C HitchmanDepartment of Addictions, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.ORCID 0000-0001-6155-6916
Richard J O'ConnorDepartment of Health Behavior, Roswell Park Cancer Institute, Buffalo, New York, USA.
David T LevyDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.ORCID 0000-0001-5280-3612
K Michael CummingsPsychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0002-7103-7017

Funding

Vaporized Nicotine Product Initiation Among Youth in the US, Canada, and England: Methods to Predict Uptake and Policy EfficacyP01CA200512 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HAMMOND, DAVID · 2016 to 2025
$25.3M
Personalized Smoking Relapse Prevention Delivered in Real-Time via Just-in-time Adaptive InterventionsK23DA041616 · NIDA · MEHARRY MEDICAL COLLEGE · PI HECKMAN, BRYAN WAYNE · 2017 to 2021
$929k
NCI NIH HHS P01 CA200512NIDA NIH HHS K23 DA041616
6 · The paper itself

Abstract

STUDY

objectivesTo compare the prices paid for nicotine vaping products (NVPs) and supplies among current NVP users to prices paid for cigarettes among current smokers. DATA: The 2016 International Tobacco Control Four Country Vaping and Smoking Survey (4CV1). Key measures included: (1) self-reported prices paid for reusable NVPs (eg, rechargeable devices with cartridges and tank system devices with e-liquids) in the 3-month period prior to the survey among current NVP users, (2) prices paid for disposable NVPs, cartridges and e-liquids purchased in the last 30 days among current NVP users and (3) self-reported prices paid for cigarettes among current smokers.

resultsDisposable NVP price was higher than the price of a comparable unit for combustible cigarettes in England (EN), USA and Canada (CA). Prefilled cartridge price was higher than the price of a comparable unit of cigarettes in USA and CA, but lower in EN and Australia. E-liquid price was consistently lower than the price of a comparable unit of cigarettes across four countries. For start-up costs, price of a rechargeable device is approximately 3-5 times higher than a pack of cigarettes in four countries.

conclusionNVP prices were generally higher than prices of combustible cigarettes, especially the high upfront NVP devices. The high upfront costs of purchasing a reusable NVP may discourage some smokers from switching to vaping. However, the average lower costs of cartridges and e-liquids relative to a package of cigarettes make switching to a NVP an attractive alternative to smoking in the long term so long as smokers switch completely to vaping.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationTobacco ProductsVapingHumansSmokersSmokingelectronic nicotine delivery devicesnon-cigarette tobacco productsprice

Identifiers

PMID32086385
PMCPMC7507861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.